Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 5/20 | 0.66 |
| ▸ | HTR2A | P28223 | 5/20 | 0.66 |
| ▸ | HTR2C | P28335 | 5/20 | 0.66 |
| ▸ | ACHE | P22303 | 2/20 | 0.62 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9378097 | 0.91 | DRD2 (0.62) | DRD2HTR2AHTR2CACHESLC6A4 | |
| SCHEMBL9383070 | 0.91 | DRD2 (0.62) | DRD2HTR2AHTR2CACHESLC6A4 | |
| SCHEMBL9381946 | 0.86 | HTR2A (0.82) | DRD2HTR2AHTR2CACHESLC6A4 | |
| Fumaric Acid SCHEMBL9682253 | 0.84 | DRD2 (0.57) | DRD2HTR2AHTR2CACHESLC6A4 | |
| Fumaric Acid SCHEMBL9682262 | 0.84 | DRD2 (0.57) | DRD2HTR2AHTR2CACHESLC6A4 | |
| SCHEMBL9187663 | 0.82 | HTR2A (0.53) | DRD2HTR2AHTR2C | |
| SCHEMBL9384231 | 0.82 | DRD2 (0.64) | DRD2HTR2AHTR2CACHESLC6A4 | |
| Hydrochloric Acid SCHEMBL9722317 | 0.82 | HTR2A (0.52) | DRD2HTR2AHTR2C | |
| SCHEMBL8871775 | 0.81 | ACHE (0.77) | DRD2HTR2AHTR2CACHESLC6A4 | |
| SCHEMBL1545818 | 0.80 | ACHE (0.72) | DRD2HTR2AHTR2CACHESLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2600863-B1 | USE OF SIGMA LIGANDS IN OPIOID-INDUCED HYPERALGESIA | ESTEVE LABOR DR (ES) | 2018-03-28 | — | — | EP | disclosed |
| EP-2646025-B1 | USE OF SIGMA LIGANDS IN BONE CANCER PAIN | ESTEVE LABOR DR (ES) | 2017-03-15 | — | — | EP | disclosed |
| EP-2531191-B1 | Sigma ligands for use in the prevention and/or treatment of postoperative pain | ESTEVE LABOR DR (ES) | 2016-03-30 | — | — | EP | disclosed |
| EP-2571501-B1 | SIGMA LIGANDS FOR THE PREVENTION AND/OR TREATMENT OF EMESIS INDUCED BY CHEMOTHERAPY OR RADIOTHERAPY | ESTEVE LABOR DR (ES) | 2016-03-02 | — | — | EP | disclosed |
| EP-2460519-A1 | Use of sigma ligands in bone cancer pain | Laboratorios Del. Dr. Esteve, S.A. (ES) | 2012-06-06 | — | — | EP | disclosed |
| EP-2415471-A1 | Use of sigma ligands in opioid-induced hyperalgesia | Laboratorios Del. Dr. Esteve, S.A. (ES) | 2012-02-08 | — | — | EP | disclosed |
| EP-2388005-A1 | Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy | Laboratorios Del. Dr. Esteve, S.A. (ES) | 2011-11-23 | — | — | EP | disclosed |
| EP-2353598-A1 | Sigma ligands for use in the prevention and/or treatment of postoperative pain | Laboratorios Del. Dr. Esteve, S.A. (ES) | 2011-08-10 | — | — | EP | disclosed |